Company page

Amgen Inc.

Amgen Inc. is a publicly traded biotechnology company listed under the ticker AMG, operating in the German market. The company has a market capitalization of approximately €182.21 billion. Amgen focuses on developing innovative therapies to address serious illnesses and improve patient outcomes.

profileAMGN:NASDAQAI content: aiUpdated June 24, 2026/company/amgen-inc/c-dpkysxh4
Amgen Inc. logo
Ticker
AMGN:NASDAQ
Asset type
Stock
Market cap
$182.21B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD